M
MTM Laboratories
Innovates and manufactures instruments and reagents that automate tissue processing and slide staining
About MTM Laboratories
MTM Laboratories, a subsidiary of Roche Diagnostics, is a key player in the healthcare diagnostics industry. The company specializes in providing in vitro diagnostic solutions, which are tests done on samples such as blood or tissue that have been taken from the human body. These solutions help healthcare professionals diagnose and manage diseases more effectively. MTM Laboratories also offers instrument systems and services that support these diagnostic tests.
The company operates in several markets, including centralized and point-of-care solutions, molecular diagnostics, tissue diagnostics, and sequencing. Centralized solutions refer to diagnostic tests conducted in large laboratories, while point-of-care solutions are tests done at or near the site of patient care. Molecular diagnostics involve analyzing biological markers in the genome and proteome to diagnose and monitor diseases. Tissue diagnostics focus on staining and instrument systems that automate the tissue diagnostic process, providing faster and more standardized results. Sequencing involves reading the genetic code to help in diagnosing and treating diseases.
MTM Laboratories serves a wide range of clients, including hospitals, clinics, and research institutions. The company’s business model revolves around selling diagnostic instruments and tests, as well as providing ongoing services and support to ensure these tools are used effectively. Revenue is generated through the sale of these products and services, as well as through partnerships and collaborations with other healthcare organizations.
In summary, MTM Laboratories is dedicated to improving healthcare outcomes by providing advanced diagnostic solutions. The company plays a crucial role in the global fight against infectious diseases, including COVID-19 and HIV/AIDS, by offering innovative testing and diagnostic tools.
Source: Dealroom company dataAt a glance
- Status
- Acquired
- Founded
- 1999
- Headquarters
- Oro Valley, United States
- Employees
- 565
- Open positions
- None listed
- Dealroom signal
- 60.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Tissue Engineering, Spinout, Process Technologies, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
Growth signals
Latest recorded traffic for MTM Laboratories is 0 monthly website visits. MTM Laboratories's team declined 45.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Heidelberg Innovation
HBM Healthcare Investments
Wellington Partners
Series B and later1 investor entered at this stage
Gilde Healthcare
Other known investors2 additional known investors
DKFZ German Cancer Research Center- HEHeidelberg-university-hospital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MTM Laboratories on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MTM Laboratories’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.